Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 062548/0762 | |
| Pages: | 9 |
| | Recorded: | 01/31/2023 | | |
| Attorney Dkt #: | PRTX-046-US07-CNT |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17903700
|
Filing Dt:
|
09/06/2022
|
|
Publication #:
|
|
Pub Dt:
|
07/27/2023
| | | | |
|
Title:
|
IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE
|
|
|
Assignee
|
|
|
|
|
| ONE AMGEN CENTER DRIVE |
| THOUSAND OAKS, CALIFORNIA 91320-1799 |
|
|
Correspondence name and address
|
| |
AMGEN INC.
|
| |
ONE AMGEN CENTER DRIVE
|
| |
LAW DEPT-PATENT OPERATIONS, MS 28-5-A
|
| |
THOUSAND OAKS, CA 91320-1799
|
Search Results as of:
09/22/2024 10:34 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
